Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technology
Alzheimer’s disease (AD) is the leading cause of dementia, accounting for an estimated 60-80% of cases worldwide. Presently, there is no effective treatment for AD and only very limited medicines show the potential for delaying the progression of this neurodegenerative disease at its early stage. On the other hand, amnestic mild cognitive impairment
Robotic Method Marks the End of Uncertainty in Parkinson’s Hallucinations in Disease
A study comprising of 26 patients with Parkinson’s disease (PD) utilized a robotic method to initiate “presence hallucinations” and found that altered sensorimotor processing in the frontotemporal network could be the cause behind hallucinations that are experienced by the PD patients. These findings led to the identification of the neural network that is responsible for […]